Synthesis and 5HT modulating activity of stereoisomers of 3-phenoxymethyl-4-phenylpiperidines

被引:25
作者
Engelstoft, M
Hansen, JB
机构
[1] Novo Nordisk A/S, Medicinal Chemistry, Novo Nordisk Park
来源
ACTA CHEMICA SCANDINAVICA | 1996年 / 50卷 / 02期
关键词
D O I
10.3891/acta.chem.scand.50-0164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of pairs of enantiomers of substituted 3-phenoxymethyl-4-phenylpiperidines has been prepared from arecoline or alpha-methylstyrene by a combination of stereospecific reactions and optical resolutions. The ability of the compounds to modulate serotonin (5HT) neurotransmission in vitro was determined. Several derivatives, among which is the antidepressant paroxetine, are very potent inhibitors of 5HT reuptake. These compounds exhibit a pronounced steric requirement for inhibition of 5HT reuptake and binding to 5HT(2A) and 5HT(2C) receptors.
引用
收藏
页码:164 / 169
页数:6
相关论文
共 30 条
[1]   PHARMACOLOGICAL PROFILE OF A NOVEL NEURONAL CALCIUM-CHANNEL BLOCKER INCLUDES REDUCED CEREBRAL-DAMAGE AND NEUROLOGICAL DEFICITS IN RAT FOCAL ISCHEMIA [J].
BARONE, FC ;
PRICE, WJ ;
JAKOBSEN, P ;
SHEARDOWN, MJ ;
FEUERSTEIN, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 48 (01) :77-85
[2]   NEUROBIOLOGICAL MECHANISMS INVOLVED IN ANTIDEPRESSANT THERAPIES [J].
BRILEY, M ;
MORET, C .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) :387-400
[3]  
BURIS KD, 1991, J PHARMACOL EXP THER, V258, P891
[4]  
Christensen J. A., 1977, 4-Phenylpiperidine compounds, Patent No. [US4007196A, 4007196]
[5]   ON THE FORMATION OF THE 1-AZA-[3.1.1]-BICYCLOHEPTANE RING-SYSTEM [J].
CHRISTENSEN, JA ;
ENGELSTOFT, M ;
SCHAUMBURG, K ;
SCHOU, H ;
WATJEN, F .
TETRAHEDRON LETTERS, 1983, 24 (46) :5151-5152
[6]   COMPOUNDS AFFECTING CENTRAL NERVOUS-SYSTEM .4. 3BETA-PHENYLTROPANE-2-CARBOXYLIC ESTERS AND ANALOGS [J].
CLARKE, RL ;
DAUM, SJ ;
GAMBINO, AJ ;
ACETO, MD ;
PEARL, J ;
LEVITT, M ;
CUMISKEY, WR ;
BOGADO, EF .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (11) :1260-1267
[7]   NEURONAL UPTAKE INHIBITORS, NISOXETINE AND FLUOXETINE ON RAT VASCULAR CONTRACTIONS [J].
COHEN, ML ;
WILEY, KS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 44 (03) :219-229
[8]   PAROXETINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN DEPRESSIVE-ILLNESS [J].
DECHANT, KL ;
CLISSOLD, SP .
DRUGS, 1991, 41 (02) :225-253
[9]   COMPARISON OF NORFLUOXETINE ENANTIOMERS AS SEROTONIN UPTAKE INHIBITORS INVIVO [J].
FULLER, RW ;
SNODDY, HD ;
KRUSHINSKI, JH ;
ROBERTSON, DW .
NEUROPHARMACOLOGY, 1992, 31 (10) :997-1000
[10]   MPTP MECHANISMS OF NEUROTOXICITY AND THEIR IMPLICATIONS FOR PARKINSONS-DISEASE [J].
GERLACH, M ;
RIEDERER, P ;
PRZUNTEK, H ;
YOUDIM, MBH .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 208 (04) :273-286